tetano
Editor, Senior Moderator
Clin Exp Dermatol
. 2021 Oct 7.
doi: 10.1111/ced.14970. Online ahead of print.
Abrupt onset of Sweet syndrome, Pityriasis Rubra Pilaris, Pityriasis lichenoides et varioliformis acuta, and Erythema multiforme unraveling a possible common trigger: Covid-19 vaccine
A Sechi[SUP] 1 2 [/SUP], E Pierobon[SUP] 3 [/SUP], E Pezzolo[SUP] 1 [/SUP], L Germi[SUP] 1 [/SUP], G Trevisan[SUP] 1 [/SUP], D Zardo[SUP] 4 [/SUP], G Riva[SUP] 4 [/SUP], S Mondino[SUP] 5 [/SUP], L Naldi[SUP] 1 [/SUP]
Affiliations
Abstract
Developing and manufacturing effective vaccines against Coronavirus Disease 2019 (COVID-19) have been epic achievements in record time. We believe that the vaccine will help stop the pandemic due to the SARS-CoV-2 virus. As for other medical interventions, vaccines may carry a small risk of adverse reactions, especially when used on large populations outside the highly controlled phase 3 clinical trials setting. We herein report five cases of heterogeneous rare, severe cutaneous conditions arising in close connection with Covid-19 vaccination (Table 1).
. 2021 Oct 7.
doi: 10.1111/ced.14970. Online ahead of print.
Abrupt onset of Sweet syndrome, Pityriasis Rubra Pilaris, Pityriasis lichenoides et varioliformis acuta, and Erythema multiforme unraveling a possible common trigger: Covid-19 vaccine
A Sechi[SUP] 1 2 [/SUP], E Pierobon[SUP] 3 [/SUP], E Pezzolo[SUP] 1 [/SUP], L Germi[SUP] 1 [/SUP], G Trevisan[SUP] 1 [/SUP], D Zardo[SUP] 4 [/SUP], G Riva[SUP] 4 [/SUP], S Mondino[SUP] 5 [/SUP], L Naldi[SUP] 1 [/SUP]
Affiliations
- PMID: 34617317
- DOI: 10.1111/ced.14970
Abstract
Developing and manufacturing effective vaccines against Coronavirus Disease 2019 (COVID-19) have been epic achievements in record time. We believe that the vaccine will help stop the pandemic due to the SARS-CoV-2 virus. As for other medical interventions, vaccines may carry a small risk of adverse reactions, especially when used on large populations outside the highly controlled phase 3 clinical trials setting. We herein report five cases of heterogeneous rare, severe cutaneous conditions arising in close connection with Covid-19 vaccination (Table 1).